Dong-A Socio Holdings Co., Ltd. (000640.KS)
KRW 110000.0
(4.86%)
KRW 110000.0
(4.86%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 117.85 Billion KRW | 19.05% |
| 2022 | 98.99 Billion KRW | 30.16% |
| 2021 | 76.05 Billion KRW | -4.51% |
| 2020 | 79.64 Billion KRW | 6.67% |
| 2019 | 74.66 Billion KRW | -8.23% |
| 2018 | 81.36 Billion KRW | 5.31% |
| 2017 | 77.26 Billion KRW | -9.73% |
| 2016 | 85.58 Billion KRW | -44.69% |
| 2015 | 154.73 Billion KRW | 26.02% |
| 2014 | 122.79 Billion KRW | 14.21% |
| 2013 | 107.51 Billion KRW | -41.3% |
| 2012 | 183.16 Billion KRW | 18.21% |
| 2011 | 154.94 Billion KRW | 32.0% |
| 2010 | 117.38 Billion KRW | -2.56% |
| 2009 | 120.46 Billion KRW | 8.51% |
| 2008 | 111.02 Billion KRW | 14.93% |
| 2007 | 96.6 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 157.65 Billion KRW | 20.77% |
| 2024 Q1 | 130.54 Billion KRW | 10.77% |
| 2023 FY | 117.85 Billion KRW | 19.05% |
| 2023 Q2 | 101.7 Billion KRW | -2.96% |
| 2023 Q1 | 104.8 Billion KRW | 5.87% |
| 2023 Q3 | 119.9 Billion KRW | 17.89% |
| 2023 Q4 | 117.85 Billion KRW | -1.71% |
| 2022 Q4 | 98.99 Billion KRW | -4.98% |
| 2022 FY | 98.99 Billion KRW | 30.16% |
| 2022 Q3 | 104.18 Billion KRW | 8.55% |
| 2022 Q2 | 95.97 Billion KRW | 10.6% |
| 2022 Q1 | 86.78 Billion KRW | 14.1% |
| 2021 Q4 | 76.05 Billion KRW | -16.0% |
| 2021 FY | 76.05 Billion KRW | -4.51% |
| 2021 Q3 | 90.54 Billion KRW | 12.05% |
| 2021 Q2 | 80.8 Billion KRW | 2.96% |
| 2021 Q1 | 78.48 Billion KRW | -1.46% |
| 2020 Q3 | 78.69 Billion KRW | 4.69% |
| 2020 Q1 | 71.6 Billion KRW | -4.1% |
| 2020 Q2 | 75.17 Billion KRW | 4.98% |
| 2020 Q4 | 79.64 Billion KRW | 1.21% |
| 2020 FY | 79.64 Billion KRW | 6.67% |
| 2019 Q3 | 67.4 Billion KRW | -22.63% |
| 2019 Q4 | 74.66 Billion KRW | 10.78% |
| 2019 Q2 | 87.12 Billion KRW | 8.06% |
| 2019 Q1 | 80.62 Billion KRW | -0.91% |
| 2019 FY | 74.66 Billion KRW | -8.23% |
| 2018 Q4 | 81.36 Billion KRW | 1.68% |
| 2018 FY | 81.36 Billion KRW | 5.31% |
| 2018 Q2 | 78.92 Billion KRW | -0.12% |
| 2018 Q1 | 79.02 Billion KRW | 2.28% |
| 2018 Q3 | 80.01 Billion KRW | 1.38% |
| 2017 Q4 | 77.26 Billion KRW | 2.46% |
| 2017 Q3 | 75.4 Billion KRW | -12.72% |
| 2017 Q2 | 86.39 Billion KRW | 1.2% |
| 2017 FY | 77.26 Billion KRW | -9.73% |
| 2017 Q1 | 85.37 Billion KRW | -0.25% |
| 2016 FY | 85.58 Billion KRW | -44.69% |
| 2016 Q2 | 106.38 Billion KRW | -38.3% |
| 2016 Q3 | 110.3 Billion KRW | 3.68% |
| 2016 Q4 | 85.58 Billion KRW | -22.4% |
| 2016 Q1 | 172.42 Billion KRW | 11.43% |
| 2015 Q4 | 154.73 Billion KRW | 9.17% |
| 2015 Q3 | 141.73 Billion KRW | 3.64% |
| 2015 FY | 154.73 Billion KRW | 26.02% |
| 2015 Q1 | 130.89 Billion KRW | 6.6% |
| 2015 Q2 | 136.76 Billion KRW | 4.48% |
| 2014 Q3 | 140.07 Billion KRW | 5.55% |
| 2014 FY | 122.79 Billion KRW | 14.21% |
| 2014 Q4 | 122.79 Billion KRW | -12.34% |
| 2014 Q2 | 132.71 Billion KRW | 25.98% |
| 2014 Q1 | 105.34 Billion KRW | -2.02% |
| 2013 Q2 | 102.9 Billion KRW | 2.28% |
| 2013 Q3 | 115.1 Billion KRW | 11.85% |
| 2013 FY | 107.51 Billion KRW | -41.3% |
| 2013 Q4 | 107.51 Billion KRW | -6.59% |
| 2013 Q1 | 100.61 Billion KRW | -45.07% |
| 2012 Q1 | 127.91 Billion KRW | 0.0% |
| 2012 Q4 | 183.16 Billion KRW | 0.0% |
| 2012 FY | 183.16 Billion KRW | 18.21% |
| 2011 Q2 | 115.6 Billion KRW | -2.48% |
| 2011 FY | 154.94 Billion KRW | 32.0% |
| 2011 Q1 | 118.54 Billion KRW | 0.0% |
| 2011 Q3 | 109.67 Billion KRW | -5.13% |
| 2010 Q3 | 112.42 Billion KRW | 2.9% |
| 2010 Q1 | 111.35 Billion KRW | 0.0% |
| 2010 Q2 | 109.25 Billion KRW | -1.88% |
| 2010 FY | 117.38 Billion KRW | -2.56% |
| 2009 Q1 | 124.61 Billion KRW | 0.0% |
| 2009 Q2 | 136.3 Billion KRW | 9.38% |
| 2009 FY | 120.46 Billion KRW | 8.51% |
| 2009 Q3 | 125.65 Billion KRW | -7.81% |
| 2008 Q3 | 99.38 Billion KRW | 8.72% |
| 2008 Q1 | 86.01 Billion KRW | 0.0% |
| 2008 Q2 | 91.41 Billion KRW | 6.28% |
| 2008 FY | 111.02 Billion KRW | 14.93% |
| 2007 Q1 | 85.98 Billion KRW | 0.0% |
| 2007 Q2 | 90.03 Billion KRW | 4.71% |
| 2007 Q3 | 96.24 Billion KRW | 6.9% |
| 2007 FY | 96.6 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -166.923% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | -29.272% |
| HANDOK Inc. | 94.46 Billion KRW | -24.758% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -454.779% |
| Yuhan Corporation | 284.75 Billion KRW | 58.613% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | -1.323% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -624.858% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 59.194% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -263.92% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -90.932% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -505.083% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -289.205% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -143.762% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -166.923% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -277.239% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -235.032% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -144.872% |
| JW Holdings Corporation | 147.58 Billion KRW | 20.149% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -39.267% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 54.92% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -11.086% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -118.556% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -336.523% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -262.495% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | -7.365% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -166.923% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 37.526% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 51.209% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -11.086% |
| Yuhan Corporation | 284.75 Billion KRW | 58.613% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | 5.929% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -90.125% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 54.645% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -11.086% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -48.051% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -139.82% |
| CKD Bio Corp. | 69.08 Billion KRW | -70.597% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | -12.157% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -66.7% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -118.011% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -118.556% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 39.49% |
| Boryung Corporation | 189.8 Billion KRW | 37.909% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -107.37% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -90.932% |
| JW Lifescience Corporation | 23.39 Billion KRW | -403.672% |